IMMUNOGLOBULIN CONSTRUCT CONTAINING TUMOR SPECIFIC P53BP2 SEQUENCES FOR ELICITING AN ANTI-TUMOR RESPONSE

Details for Australian Patent Application No. 2002303206 (hide)

Owner PURDUE PHARMA L.P.

Inventors NICOLETTE, Charles, A.; SOLTIS, Daniel, A.

Pub. Number AU-A-2002303206

PCT Number PCT/US02/10224

PCT Pub. Number WO2002/078609

Priority 60/280,733 30.03.01 US

Filing date 1 April 2002

Wipo publication date 15 October 2002

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/280,733 30.03.01 US

3 April 2003 Application Open to Public Inspection

  Published as AU-A-2002303206

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303207-A remote baggage screening system, software and method

2002303205-METHOD AND APPARATUS FOR SELECTIVE BIOLOGICAL MATERIAL DETECTION